Live Breaking News & Updates on Nirmalya mohapatra

Stay informed with the latest breaking news from Nirmalya mohapatra on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Nirmalya mohapatra and stay connected to the pulse of your community

Health minister asks Indian yoga guru to withdraw virus claims

NEW DELHI: In the wake of widespread outrage coming from doctors, India’s Health Minister Dr. Harsh Vardhan has asked controversial yoga guru Baba Ramdev to withdraw his recent comments blaming heath workers for huge numbers of coronavirus deaths as the country is in a grip of a second wave of the pandemic.
“The people of the country are very hurt with your remark on allopathic medicines,” Harshvardhan said in an open letter to Ramdev.
“You have not only insulted corona warriors, but have hurt the feelings of the people of the country,” he said, as he asked the guru to “think hard on it and withdraw your statements completely.”

India , Haridwar , Uttaranchal , New-delhi , Delhi , Pune , Maharashtra , Harsh-vardhan , Prashant-munde , Nirmalya-mohapatra , Baba-ramdev , Harjit-singh-bhatti

COVID-19 LIVE UPDATES | US administers 80.5m doses of Covid-19 vaccines

Coronavirus updates.

West-midlands , United-kingdom-general , United-kingdom , London , City-of , Steven-riley , Imperial-college-london , Infectious-disease-dynamics , Vaccines , Co-vid , Doses , Cdc

Efficacy data for India's own coronavirus vaccine could boost its public acceptance

Efficacy data for India's own coronavirus vaccine could boost its public acceptance
SECTIONS
Last Updated: Mar 04, 2021, 03:18 PM IST
Share
Synopsis
Any boost to the vaccine's acceptance in India, which on Thursday reported a new COVID-19 cases at their highest in five weeks, could also brighten its export prospects. Bharat Biotech said 40 countries were interested in COVAXIN.
Bharat Biotech Covaxin Efficacy Data: How effective is the vaccine?
Indian doctors and politicians on Thursday welcomed efficacy data for a state-backed coronavirus vaccine that was given emergency approval in January without the completion of a late-stage trial, making people reluctant to receive the shot.

India , New-delhi , Delhi , Bharat , Nirmalya-mohapatra , Rajib-dasgupta , Ram-manohar-lohia , Shashi-tharoor , Oxford-university-astrazeneca , Twitter , Bharat-biotech , Ram-manohar-lohia-hospital

Efficacy data for India's own COVID-19 vaccine could boost public acceptance | WSAU News/Talk 550 AM · 99.9 FM

By Krishna N. Das NEW DELHI (Reuters) - Indian doctors and politicians on Thursday welcomed efficacy data for a state-backed coronavirus vaccine that ...

Bengaluru , Karnataka , India , New-delhi , Delhi , Bharat , Krishnan-das , Nirmalya-mohapatra , Rajib-dasgupta , Ram-manohar-lohia , Philip-george , Shashi-tharoor

COVID-19 vaccination: Covaxin's efficacy data likely to bolster public acceptance

Government data shows that only 10% of about 12.6 million people immunised in India have taken the COVAXIN shot, which was found to be 81% effective in an interim analysis of the late-stage trial, its developer Bharat Biotech said

India , United-kingdom , New-delhi , Delhi , Bharat , Nirmalya-mohapatra , Rajib-dasgupta , Ram-manohar-lohia , Shashi-tharoor , Oxford-university-astrazeneca , Twitter , Bharat-biotech

Efficacy data for India's Covid-19 vaccine could boost public acceptance

Indian doctors and politicians welcomed efficacy data for a state-backed coronavirus vaccine that was given emergency approval in January without the completion of a late-stage trial, making people reluctant to receive the shot.

India , Mumbai , Maharashtra , New-delhi , Delhi , Bharat , Nirmalya-mohapatra , Rajib-dasgupta , Ram-manohar-lohia , Shashi-tharoor , Astrazeneca , Oxford-university-astrazeneca

India's COVID vaccine wins over some sceptics after promising data

Indian doctors and politicians on Thursday welcomed efficacy data for a state-backed coronavirus vaccine that was given emergency approval in January without the completion of a late-stage trial, making people reluctant to receive the shot.

Bengaluru , Karnataka , India , New-delhi , Delhi , Zimbabwe , Bharat , Krishnan-das , Rajib-dasgupta , Shashi-tharoor , Simon-cameron-moore , Nirmalya-mohapatra

India's COVID-19 vaccine wins over some sceptics after promising data

India's COVID-19 vaccine wins over some sceptics after promising data
channelnewsasia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from channelnewsasia.com Daily Mail and Mail on Sunday newspapers.

India , New-delhi , Delhi , Zimbabwe , Bharat , Nirmalya-mohapatra , Rajib-dasgupta , Ram-manohar-lohia , Shashi-tharoor , Astrazeneca , Twitter , Oxford-university

India's COVID vaccine wins over some sceptics after promising data

India's COVID vaccine wins over some sceptics after promising data
reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.

Bengaluru , Karnataka , India , New-delhi , Delhi , Zimbabwe , Bharat , Krishnan-das , Rajib-dasgupta , Shashi-tharoor , Simon-cameron-moore , Nirmalya-mohapatra

Efficacy data for India's own COVID-19 vaccine could boost public acceptance

Efficacy data for India's own COVID-19 vaccine could boost public acceptance
netscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from netscape.com Daily Mail and Mail on Sunday newspapers.

Bengaluru , Karnataka , India , New-delhi , Delhi , Bharat , Krishnan-das , Nirmalya-mohapatra , Rajib-dasgupta , Ram-manohar-lohia , Philip-george , Shashi-tharoor